Skip to main content

Table 5 Treatment outcome of severe irAE patients

From: Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody

organ

irAE detail

grade

origin

time to last ICI

Time to first ICI

treatment

outcome

reteatment

complication

preexisting antibody

skin

whole body prurigo

3

lung

21

69

steroid po&ointment

remission

try

none

RF

skin

whole body prurigo

3

lung

12

12

steroid po,ointment &iv

remission

stop

none

TgAb,TPO,RF, ANA

Liver

elevated liver enzyms

3

renal

21

21

steroid po

remission

PD

none

ANA

pneumonitis

interstitial pneumonia

4

lung

3

3

systemic pulse steroid

death

stop

dyalisis, lymphangitis

ANA

pneumonitis

interstitial pneumonia

4

gastric

16

140

systemic pulse steroid

death

PD

none

 

pneumonitis

interstitial pneumonia

3

lung

7

31

systemic pulse steroid

 

PD

none

 

CNS

convulsion

5

malignant melanoma

17

43

systemic pulse steroid

death

stop

brain meta RTx

 

thyroid

hyposthenia

3

gastric

10

68

steroid po

remission

try

none

ANA

  1. Abbreviations: CNS Central Nervous System